Mary E Temple
Impact in
- Biotechnology top 5%
- Listeria monocytogenes in Food Safety
- Microbial Inactivation Methods
- Toxicology top 10%
Papers in
-
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Aileen B Luzier (2 shared papers)David J. Kazierad (2 shared papers)Katalin Korányi (6 shared papers)John R. Hayes (1 shared paper)Renee Robinson (1 shared paper)Janet R. Reid (1 shared paper)Susana Arrigain (1 shared paper)Steve Davis (1 shared paper)
- Journals
- Annals of Pharmacotherapy (10 papers)American Journal of Health-System Pharmacy (3 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)Pediatric Critical Care Medicine (1 paper)Expert Opinion on Pharmacotherapy (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Mary E Temple
22 papers receiving 486 citations
Peers
Comparison fields: 5 of 84
- Biotechnology 124
- Toxicology 29
- Geriatrics and Gerontology 24
- Food Science 94
- Infectious Diseases 83
Countries citing papers authored by Mary E Temple
This map shows the geographic impact of Mary E Temple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E Temple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E Temple more than expected).
Fields of papers citing papers by Mary E Temple
This network shows the impact of papers produced by Mary E Temple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E Temple. The network helps show where Mary E Temple may publish in the future.
Co-authors
The 14 scholars most cited alongside Mary E Temple, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 154 | |
| 2 | 2000 | 65 | |
| 3 | 2004 | 63 | |
| 4 | 2005 | 48 | |
| 5 | 1999 | 38 | |
| 6 | 2000 | 23 | |
| 7 | 2001 | 19 | |
| 8 | 2001 | 16 | |
| 9 | 2000 | 16 | |
| 10 | 2000 | 14 | |
| 11 | 2003 | 14 | |
| 12 | 2014 | 12 | |
| 13 | 1999 | 11 | |
| 14 | 2001 | 10 | |
| 15 | 2000 | 8 | |
| 16 | 2000 | 7 | |
| 17 | 2013 | 4 | |
| 18 | 1999 | 3 | |
| 19 | 2000 | 2 | |
| 20 | 2001 | 2 |
About Mary E Temple
Mary E Temple is a scholar working on Epidemiology, Infectious Diseases, Rheumatology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 23 papers that have together received 533 indexed citations. Recurring topics across this work include Folate and B Vitamins Research (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), HIV/AIDS drug development and treatment (2 papers), Hepatitis C virus research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Listeria monocytogenes in Food Safety (2 papers), Sinusitis and nasal conditions (1 paper) and Telemedicine and Telehealth Implementation (1 paper). The work is most often cited by research in Biotechnology (124 citations), Toxicology (29 citations), Geriatrics and Gerontology (24 citations), Food Science (94 citations) and Infectious Diseases (83 citations). Mary E Temple has collaborated with scholars based in United States and India. Frequent co-authors include Aileen B Luzier, David J. Kazierad, Katalin Korányi, John R. Hayes, Renee Robinson, Janet R. Reid, Susana Arrigain, Steve Davis, A. Marc Harrison and Stuart C. Morrison. Their work appears in journals such as Annals of Pharmacotherapy, American Journal of Health-System Pharmacy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Pediatric Critical Care Medicine and Expert Opinion on Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.